All CIRM Grants

Search Filters »

Institution Researcher name Grant Type Grant Title Award Value
University of California, San Diego Dr. Charles C. King Dr. Basic Biology III Biological relevance of microRNAs in hESC differentiation to endocrine pancreas $1,313,649
University of California, Berkeley Dr. Song Li Basic Biology III Induced Pluripotent Stem Cells for Tissue Regeneration $1,209,148
University of California, San Diego Karl H. Willert Tools and Technologies II Homologous recombination in human pluripotent stem cells using adeno-associated virus. $1,659,043
Stanford University Dr. Marius Wernig MD, PhD Tools and Technologies II Cellular tools to study brain diseases affecting synaptic transmission $1,664,382
Stanford University Dr. Irving L Weissman MD Tools and Technologies II Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs $1,463,814
TriFoil Imaging, Inc. Dr. Joann Zhang Tools and Technologies II Tri-resolution Visualization System for Stem Cells and Tissue Regeneration Monitoring $1,456,989
Cedars-Sinai Medical Center Professor Clive Niels Svendsen Tools and Technologies II Use of iPS cells (iPSCs) to develop novels tools for the treatment of spinal muscular atrophy. $1,933,022
University of California, Berkeley Dr. David V. Schaffer Tools and Technologies II Engineering Defined and Scaleable Systems for Dopaminergic Neuron Differentiation of hPSCs $1,340,816
Stanford University Dr. Brian K. Rutt Tools and Technologies II Development of Single Cell MRI Technology using Genetically-Encoded Iron-Based Reporters $1,833,348
Parkinson’s Institute Dr. Birgitt Schuele Tools and Technologies II Editing of Parkinson’s disease mutation in patient-derived iPSCs by zinc-finger nucleases $1,327,983
University of California, San Francisco Dr Daniel A. Lim MD, PHD Tools and Technologies II Development and preclinical testing of new devices for cell transplantation to the brain. $1,795,891
GMR Epigenetics Dr. Jifan Hu Tools and Technologies II Robust generation of induced pluripotent stem cells by a potent set of engineered factors $1,356,052
Stanford University Dr. Sarah C Heilshorn Tools and Technologies II Preparation and Delivery of Clinically Relevant Numbers of Stem Cells Using 3D Hydrogels $600,695
University of California, San Diego Dr. Lawrence S. B. Goldstein Tools and Technologies II Developing a method for rapid identification of high-quality disease specific hIPSC lines $1,686,069
University of California, Los Angeles Dr. Richard A. Gatti Tools and Technologies II Use of hiPSCs to develop lead compounds for the treatment of genetic diseases $1,833,054
Stanford University Dr. Theo D. Palmer PhD Tools and Technologies II Development of small molecule screens for autism using patient-derived iPS cells $1,797,606
University of California, Berkeley Dr. Steven M. Conolly Tools and Technologies II Magnetic Particle Imaging: A Novel Ultra-sensitive Imaging Scanner for Tracking Stem Cells In Vivo $1,311,596
University of California, San Diego Shu Chien Tools and Technologies II Development of Synthetic Microenvironments for Stem Cell Growth and Differentiation $1,706,628
University of California, Los Angeles Dr. Thomas Carmichael M.D., Ph.D. Tools and Technologies II Development of a Hydrogel Matrix for Stem Cell Growth and Neural Repair after Stroke $1,825,613
Stanford University Dr. Michele Calos Tools and Technologies II Site-specific integration of Lmx1a, FoxA2, & Otx2 to optimize dopaminergic differentiation $1,592,897
Fluidigm Corporation Dr. Marc A Unger Tools and Technologies II Development and Application of Versatile, Automated, Microfluidic Cell Culture System $1,939,236
University of California, Los Angeles Dr. Martin Gabriel Martin Tools and Technologies II Pluripotent and Somatic Stem Cell Models to Study Inherited Diarrheal Disorders $1,783,250
University of California, Los Angeles Dr. Sophie X Deng Early Translational II Regeneration of Functional Human Corneal Epithelial Progenitor Cells $697,507
University of California, San Francisco Dr. Arturo Alvarez-Buylla Early Translational II Inhibitory Nerve Cell Precursors: Dosing, Safety and Efficacy $1,564,016
University of California, Davis Dr. Mark Zern Early Translational II Liver Cell Transplantation $4,212,621
Stanford University Dr. Michele Calos Early Translational II Stem Cell Therapy for Duchenne Muscular Dystrophy $2,267,261
University of California, Irvine Dr. Brian J. Cummings Early Translational II Neural restricted, FAC-sorted, human neural stem cells to treat traumatic brain injury $1,517,767
University of California, Los Angeles Dr. Sophie X Deng Early Translational II Regeneration of Functional Human Corneal Epithelial Progenitor Cells $1,524,947
Cedars-Sinai Medical Center Dr. Dan Gazit Early Translational II Systemic Adult Stem Cell Therapy for Osteoporosis-Related Vertebral Compression Fractures $1,927,698
University of California, Los Angeles Leif Havton Early Translational II Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons $75,628
University of California, Irvine Leif A Havton Early Translational II Repair of Conus Medullaris/Cauda Equina Injury using Human ES Cell-Derived Motor Neurons $1,527,011
City of Hope, Beckman Research Institute Dr. Yanhong Shi Ph.D. Early Translational II Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell $1,835,983
City of Hope, Beckman Research Institute Dr. David Louis DiGiusto Early Translational II Development of RNA-based approaches to stem cell gene therapy for HIV $3,097,160
University of California, Davis Dr. Roslyn Rivkah Isseroff Early Translational II Bone Marrow Mesenchymal Stem Cells to Heal Chronic Diabetic Wounds $4,629,747
University of California, Los Angeles Dr. Noriyuki Kasahara Early Translational II Stem cell-based carriers for RCR vector delivery to glioblastoma $3,340,625
Salk Institute for Biological Studies Dr. Fred H Gage Early Translational II Crosstalk: Inflammation in Parkinson’s disease (PD) in a humanized in vitro model $2,472,839
University of California, Irvine Dr. Henry John Klassen Early Translational II Human retinal progenitor cells as candidate therapy for retinitis pigmentosa $1,803,768
Children’s Hospital of Los Angeles Dr. Markus Muschen Early Translational II Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication $850,769
University of California, San Francisco Markus Muschen Early Translational II Dual targeting of tyrosine kinase and BCL6 signaling for leukemia stem cell eradication $2,756,536
Buck Institute for Age Research Dr. Xianmin Zeng Early Translational II Banking transplant ready dopaminergic neurons using a scalable process $4,983,013
iPierian, Inc. Dr. John Dimos Early Translational II New Drug Discovery for SMA using Patient-derived Induced Pluripotent Stem Cells $2,410,000
University of California, Los Angeles Prof. Bruno Peault Early Translational II Harnessing native fat-residing stem cells for bone regeneration $5,359,076
Scripps Research Institute Peter G. Schultz Early Translational II Cartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis $6,047,249
University of California, San Diego Professor Alysson R Muotri Early Translational II Developing a drug-screening system for Autism Spectrum Disorders using human neurons $1,376,198
University of California, Irvine Dr. Leslie M Thompson Early Translational II A hESc-based Development Candidate for Huntington’s Disease $3,955,038
University of California, San Diego Catriona Jamieson Early Translational II Preclinical development of a pan Bcl2 inhibitor for cancer stem cell directed therapy $3,103,041
Gladstone Institutes, J. David Dr. Todd C. McDevitt Research Leadership Engineering microscale tissue constructs from human pluripotent stem cells $5,849,100
University of California, Los Angeles Dr. John P Chute Research Leadership Niche-Focused Research: Discovery & Development of Hematopoietic Regenerative Factors $4,645,297
University of California, Berkeley Dr. Xavier Darzacq Research Leadership Single Molecule Biophysics and Biology of Cellular Identity $4,175,924
University of California, San Francisco Redacted Research Leadership Recapitulating development of the musculoskeletal axis in vitro with pluripotent cells $0
1 2 3 4 5 6 7 8 9 10 11 … 29